Dr. Cheedy Jaja is an Associate Professor of Nursing. His interest in social justice, health disparities, and improving health outcomes in historically marginalized and vulnerable populations such as those with sickle cell disease drives his global health research, clinical, and advocacy initiatives in the USA and Africa.
He is one of only a few nurse scientists prepared to use pharmacogenetics strategies in pharmacotherapy for sickle cell disease with a focus on developing tailored pharmacogenetics algorithms that optimize drug selection, dosing, and monitoring strategies for sickle cell disease pain.
He has received national recognition for his research contributions as evidenced by being selected as a 2016 NIH Future Research Leader, a 2018 Fulbright Program Scholar, and a Fellow of the American Academy of Nursing in 2020.